Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- PMID: 32004406
- DOI: 10.1002/acr.24155
Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract
Objective: Despite the pivotal role that hydroxychloroquine (HCQ) plays in treating systemic lupus erythematosus (SLE), less than 50% of patients take HCQ as prescribed. Measurement of HCQ blood levels can help clinicians distinguish nonadherence versus lack of efficacy of HCQ. Our objective was to systematically review publications and perform a meta-analysis to examine the correlation between HCQ levels and 1) nonadherence and 2) Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores, in SLE.
Methods: A comprehensive search was performed. We included observational and interventional studies that measured HCQ levels and assessed adherence or SLEDAI scores in adults with SLE. Forest plots compared pooled estimates of correlations between HCQ levels and reported nonadherence or SLEDAI scores.
Results: Among 604 studies screened, 17 were reviewed. We found 3-times higher odds of reported nonadherence in patients with low HCQ levels (odds ratio 2.95 [95% confidence interval (95% CI) 1.63, 5.35], P < 0.001). The mean SLEDAI score was 3.14 points higher in groups with below-threshold HCQ levels on a priori analysis (δ = 3.14 [95% CI -0.05, 6.23], P = 0.053), and 1.4 points higher in groups with HCQ levels of <500 ng/ml (δ = 1.42 [95% CI 0.07, 2.76], P = 0.039). Among 1,223 patients, those with HCQ levels ≥750 ng/ml had a 58% lower risk of active disease, and their SLEDAI score was 3.2 points lower.
Conclusion: We found a strong association between low HCQ levels and reported nonadherence. Our results suggest that HCQ levels of ≥750 ng/ml might be a potential therapeutic target.
© 2020, American College of Rheumatology.
Comment in
-
Reply.Arthritis Care Res (Hoboken). 2022 Jan;74(1):162-163. doi: 10.1002/acr.24775. Epub 2021 Dec 10. Arthritis Care Res (Hoboken). 2022. PMID: 34459149 No abstract available.
-
Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et al.Arthritis Care Res (Hoboken). 2022 Jan;74(1):162. doi: 10.1002/acr.24776. Epub 2021 Dec 10. Arthritis Care Res (Hoboken). 2022. PMID: 34459156 No abstract available.
Similar articles
-
Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.Lupus. 2019 Jun;28(7):862-867. doi: 10.1177/0961203319851558. Epub 2019 May 24. Lupus. 2019. PMID: 31122136
-
Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.Arthritis Care Res (Hoboken). 2016 Sep;68(9):1295-302. doi: 10.1002/acr.22837. Epub 2016 Jul 27. Arthritis Care Res (Hoboken). 2016. PMID: 26749299
-
Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.Arthritis Care Res (Hoboken). 2017 Apr;69(4):536-542. doi: 10.1002/acr.22962. Epub 2017 Mar 7. Arthritis Care Res (Hoboken). 2017. PMID: 27390146
-
Adherence to treatment in systemic lupus erythematosus patients.Best Pract Res Clin Rheumatol. 2013 Jun;27(3):329-40. doi: 10.1016/j.berh.2013.07.001. Best Pract Res Clin Rheumatol. 2013. PMID: 24238690 Review.
-
Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis.Lupus Sci Med. 2024 Oct 30;11(2):e001239. doi: 10.1136/lupus-2024-001239. Lupus Sci Med. 2024. PMID: 39477333 Free PMC article.
Cited by
-
Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.J Nephrol. 2024 Nov;37(8):2201-2208. doi: 10.1007/s40620-024-02029-z. Epub 2024 Jul 24. J Nephrol. 2024. PMID: 39048780 Free PMC article.
-
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus.Pharmaceuticals (Basel). 2021 Mar 17;14(3):273. doi: 10.3390/ph14030273. Pharmaceuticals (Basel). 2021. PMID: 33802811 Free PMC article.
-
Antimalarials - old drugs are new again.Postepy Dermatol Alergol. 2022 Apr;39(2):239-244. doi: 10.5114/ada.2021.108423. Epub 2021 Aug 11. Postepy Dermatol Alergol. 2022. PMID: 35645661 Free PMC article. Review.
-
Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USA.Lupus Sci Med. 2024 Dec 23;11(2):e001290. doi: 10.1136/lupus-2024-001290. Lupus Sci Med. 2024. PMID: 39719312 Free PMC article.
-
Hydroxychloroquine an Antimalarial Drug, Exhibits Potent Antifungal Efficacy Against Candida albicans Through Multitargeting.J Microbiol. 2024 May;62(5):381-391. doi: 10.1007/s12275-024-00111-6. Epub 2024 Apr 8. J Microbiol. 2024. PMID: 38587590
References
-
- Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010;69:20-8.
-
- Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. J Rheumatol 2013;40:831-41.
-
- Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, et al. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis Rheum 2010;62:863-8.
-
- Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senecal JL, Cividino A, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus: the Canadian Hydroxychloroquine Study Group. Lupus 1998;7:80-5.
-
- Fasano S, Pierro L, Pantano I, Iudici M, Valentini G. Longterm hydroxychloroquine therapy and low-dose aspirin may have an additive effectiveness in the primary prevention of cardiovascular events in patients with systemic lupus erythematosus. J Rheumatol 2017;44:1032-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical